Par Pharmaceutical Recalls Pramipexole Dihydrochloride Extended Release Tablets
Par Pharmaceutical is recalling Pramipexole dihydrochloride extended release tablets because they contain a known impurity at levels exceeding specifications.
- Product
- Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 10370-252-11
- Category
- Drug
- Distribution
- Distributed nationwide